SKINVISIBLE, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that SKINVISIBLE, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $20.0K | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $20.0K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $20.0K | Apr 14, 2025 |
| FY2023 | Dec 31, 2022 | $279.3K | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $663.4K | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $152.6K | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $42.1K | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | $69.3K | May 14, 2020 |
| FY2018 | Dec 31, 2017 | $629.0K | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | $108.9K | Mar 23, 2018 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $20.0K | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $20.0K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $20.0K | Apr 14, 2025 |
| FY2023 | Dec 31, 2022 | $274.5K | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $660.1K | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $275.6K | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $25.6K | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | $48.6K | May 14, 2020 |
| FY2018 | Dec 31, 2017 | $586.7K | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | $71.8K | Mar 23, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.06M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($565.7K) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($2.38M) | Apr 14, 2025 |
| FY2023 | Dec 31, 2022 | ($1.22M) | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | ($1.07M) | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | ($1.45M) | Mar 31, 2022 |
| FY2019 | Dec 31, 2019 | ($1.70M) | May 14, 2020 |
| FY2019 | Dec 31, 2018 | $158.3K | May 14, 2020 |
| FY2018 | Dec 31, 2017 | ($1.83M) | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | ($2.05M) | Mar 23, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($496.3K) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($589.6K) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($490.4K) | Apr 14, 2025 |
| FY2023 | Dec 31, 2022 | ($238.4K) | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $188.1K | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | ($253.7K) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($539.8K) | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | ($597.9K) | May 14, 2020 |
| FY2018 | Dec 31, 2017 | ($364.2K) | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | ($841.7K) | Mar 23, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $496.1K | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $589.2K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $491.6K | Apr 14, 2025 |
| FY2023 | Dec 31, 2022 | $494.2K | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $454.1K | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $497.2K | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $525.8K | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | $607.6K | May 14, 2020 |
| FY2018 | Dec 31, 2017 | $896.5K | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | $855.9K | Mar 23, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($38.4K) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($69.8K) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($77.2K) | Apr 14, 2025 |
| FY2023 | Dec 31, 2022 | $45.2K | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $374.6K | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $45.8K | Mar 31, 2022 |
| FY2019 | Dec 31, 2019 | ($128.2K) | May 14, 2020 |
| FY2019 | Dec 31, 2018 | ($34.3K) | May 14, 2020 |
| FY2018 | Dec 31, 2017 | ($13.9K) | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | ($244.4K) | Mar 23, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $127.6K | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $158.2K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $162.9K | Apr 14, 2025 |
| FY2023 | Dec 31, 2022 | $246.8K | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $227.3K | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $200.2K | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $181.8K | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | $220.4K | May 14, 2020 |
| FY2018 | Dec 31, 2017 | $632.2K | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | $339.6K | Mar 23, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.39M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $9.38M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $9.19M | Apr 14, 2025 |
| FY2023 | Dec 31, 2022 | $6.89M | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $5.64M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $4.66M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $3.19M | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | $4.94M | May 14, 2020 |
| FY2018 | Dec 31, 2017 | $7.39M | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | $6.45M | Mar 23, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($10.26M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($9.22M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2023 | ($9.02M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2022 | ($6.64M) | Apr 14, 2025 |
| FY2023 | Dec 31, 2021 | ($5.42M) | Apr 16, 2024 |
| FY2022 | Dec 31, 2020 | ($4.45M) | Mar 30, 2023 |
| FY2021 | Dec 31, 2019 | ($3.01M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2018 | ($4.72M) | Apr 15, 2021 |
| FY2019 | Dec 31, 2017 | ($6.76M) | May 14, 2020 |
| FY2018 | Dec 31, 2016 | ($6.11M) | Apr 15, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($41.01M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($39.95M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($39.38M) | Apr 14, 2025 |
| FY2023 | Dec 31, 2022 | ($37.00M) | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | ($35.77M) | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | ($34.70M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($33.25M) | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | ($31.55M) | May 14, 2020 |
| FY2018 | Dec 31, 2017 | ($31.71M) | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | ($29.88M) | Mar 23, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $66.0K | Mar 31, 2022 |
| FY2021 | Dec 31, 2020 | $35.9K | Mar 31, 2022 |
| FY2021 | Dec 31, 2019 | $1.3K | Mar 31, 2022 |
| FY2019 | Dec 31, 2018 | $2.5K | May 14, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 0 | Apr 14, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Apr 14, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Mar 31, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5.40M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 5.32M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 4.54M | Apr 14, 2025 |
| FY2023 | Dec 31, 2022 | 4.54M | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | 4.54M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | 4.54M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | 4.47M | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | 2.90M | May 14, 2020 |
| FY2018 | Dec 31, 2017 | 2.74M | Apr 15, 2019 |